Category: Stem cell therapy

According to a study of patients surviving at least five years post-transplant, the estimated survival probability at 20 years was over 80% for that cohort. This remarkable statistic shows that yes, it is possible to live two decades or more after a stem cell transplant, though outcomes vary significantly based on many factors.

Remarkably, studies have shown that second or even third transplants are possible in certain circumstances, with improved outcomes compared to historical data. Whether it's for the same patient or the same donor, the question of how many times can you give a bone marrow transplant involves complex medical considerations that are vital for both patient and donor safety.

While allogeneic stem cell transplants can be life-saving, a significant concern for patients is the risk of complications from a donor's cells. For many, **what is a disadvantage of using donor stem cells?** is a critical question, and the answer lies in the risk of Graft-versus-Host Disease (GVHD).

While often marketed as a miracle cure, a significant issue with exosome therapy is the lack of robust clinical evidence and regulatory oversight from bodies like the FDA, making its safety and efficacy highly uncertain. Here, we explore in detail what are the disadvantages of exosome therapy, covering everything from safety concerns to the financial burden on patients.

According to the National Marrow Donor Program, graft failure, or engraftment failure, is a rare but serious complication that can occur after a stem cell transplant. It happens when the new stem cells fail to grow and produce healthy blood cells in the bone marrow, a process known as engraftment.